Procter & Gamble reported mixed Q4 results with flat organic sales and a revenue miss, while issuing FY27 guidance below analyst estimates. Rising costs and restructuring charges are impacting profitability, leading to a negative market reaction for the stock.
Procter & Gamble's Q4 earnings report revealed flat organic sales and a revenue figure that fell short of analyst expectations, despite a slight beat on adjusted EPS. The company's core gross margin remained flat due to rising commodity costs and product reinvestments offsetting productivity savings. More significantly, P&G issued FY27 guidance for both EPS and sales that was below consensus estimates, citing substantial headwinds from higher raw material, energy, and transportation costs, as well as restructuring charges. This news is a significant negative catalyst for PG stock in the short term, as it signals ongoing margin pressures and slower growth prospects, affecting investors focused on stable, dividend-paying consumer staples. The appointment of a new Chairman also signals a leadership transition amidst these challenges.